Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00199121
Status:
UNKNOWN
Last Update Posted:
2005-12-14
First Post:
2005-09-13
Brief Title:
A Pilot Study of Triple NtRTINsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Johann Wolfgang Goethe University Hospital
Study Overview
Official Title:
An Open Single-Arm Multi-Center Phase IV Pilot Study of Treatment of Antiretroviral Naive HIV-1 Infected Patients With Tenofovir Disoproxil Fumarate in Combination With Emtricitabine and Zidovudine
Status:
UNKNOWN
Status Verified Date:
2005-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the antiviral effect and durability of antiviral response HIV-1 RNA PCR and safety of a triple NtRTINsRTI therapy in antiretroviral naive patients Patients will receive TDF plus FTC plus AZT for at least 48 weeks Further objectives are to evaluate resistance pathways in failing patients treated with TDFFTCAZT and to evaluate a treatment strategy of sparing PIs and NNRTIs for later treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None